Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor...
Transcript of Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor...
![Page 1: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/1.jpg)
Dark selection for JAK/STAT-inhibitor resistance in CMML
The Orange team, the future is bright...
![Page 2: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/2.jpg)
![Page 3: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/3.jpg)
Chronic Myelomonocytic Leukemia (CMML)
splenomegaly
CC
C
C
![Page 4: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/4.jpg)
Inflammatory cytokines are elevated in CMML
![Page 5: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/5.jpg)
Our analysis revealed prognostic links
● What are the important cytokines related to:
● Penalised regression from 48 plasma cytokine values of 161 CMML patients, prior to treatment
How patients feel? Spleen size? Survival?MCP1
PDGFAAEGF
RANTESSCF
FLT3CD44VEGF
IL12p70FGFBasic
IL5
SCFTRAIL
MIGIP10
FLT3FGFBasic
RAGE
IL12p70CD44
IL13
PDGFAARAGE
SCFRANTES
IL10
FGFBasicIL12.23p40
IL2RaExotaxin
Po
ore
rO
utc
om
eB
ette
rO
utc
om
e
![Page 6: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/6.jpg)
We lack good treatment options this lethal leukemia
Fenaux, et al Lancet Oncology 2009
![Page 7: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/7.jpg)
Ruxolitinib
Ruxolitinib: a new hope
![Page 8: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/8.jpg)
Spleen pre-/post-treatment
Ruxolitinib: a new hope
Rx
![Page 9: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/9.jpg)
Alas, resistance strikes back
Time
Sym
ptom
Bur
den
![Page 10: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/10.jpg)
We understand proximal mechanisms
![Page 11: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/11.jpg)
“Normal” resistance: Darwinian selection of resistant (epi)genotypes
Time
Dis
ease
bur
den
![Page 12: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/12.jpg)
Dark Selection: evolution paradox
No obvious impact on stem/progenitors No impact on clonal architecture
![Page 13: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/13.jpg)
Shining light on the paradox of dark selection
Unusual case of Darwinian selection Non-darwinian selection/emergence
![Page 14: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/14.jpg)
Shining light on the paradox of dark selection
![Page 15: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/15.jpg)
Scales of Cancer
![Page 16: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/16.jpg)
Alternative #1: hidden Darwinian selection
![Page 17: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/17.jpg)
Alternative #1: hidden Darwinian selection
![Page 18: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/18.jpg)
Hidden Darwinian selection is plausible
Left panel: ODE models on disease burden in the Bone MarrowRight panel: Moran process model on disease output into periphery
![Page 19: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/19.jpg)
Hidden Darwinian selection is plausible
But:No evidence of genetic changes: must be epigenetic
No evidence for reduced proliferation/increased death
![Page 20: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/20.jpg)
Considering microenvironmental pressure
Oxygen concentration strongly linked to STAT3 expression
STAT3 activation is inversely related to oxygen partial pressure. Data taken from Wang et al, Cell Biol.. Int., 2005
Increasing Hypoxia
● Hypoxia markedly increases STAT3 (and JAK) expression.● This effect seen both with and without RUX present.
● Oxygen consumption rate (OCR) markedly modulates hypoxia. ● Minor changes in OCR can lead to substantial increases in hypoxia.● Can minor OCR shifts lead to STAT3 levels > RUX can counteract?
Bone Marrow at low O2 pressure (9-32 mmHg), despite high vascularity
Slight perturbation of oxygen consumption rate leading to slightly different oxygen distributions (Grimes et al 2016, J R Soc Interface) by two vessels at the boundary. This oxygen map was set in accordance with measured O2 levels in bone marrow (Spencer et al, Nature, 2014).
Slight increases in OCR
![Page 21: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/21.jpg)
Hypoxia
Sustained stabilization of Interleukin-8 mRNA in human macrophages (Mahmoud et al 2014, RNA biology). Diffusion of Interleukin-2 from cells overlaid with cytocompatible enzyme-crosslinked gelatin hydrogen (Yung et al 2010, J Biomed Mater Res A).
![Page 22: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/22.jpg)
HypoxiaSituation 1
15.9 mmHgSituation 2
13.1 mmHgSituation 3
10.1 mmHg
Dru
gN
o D
rug
![Page 23: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/23.jpg)
Alternative #2: Dark selection/emergence
Stochastic ratcheted phenotypic switch
Lamarckian selection
Emerging signaling network behavior
![Page 24: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/24.jpg)
Alt. #2: Molecular basis of dark selection
Stochastic ratcheted phenotypic switch & Lamarkian inheritance
Rx On
Rx Off
![Page 25: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/25.jpg)
Alternative #2: Dark selection/emergence
Lamarckian non-cell autonomous
![Page 26: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/26.jpg)
Alternative #2: Dark selection/emergence
# of
cel
ls w
ith h
eter
odim
eriz
atio
n pa
thw
ays
time
change in variance
concave vs convex
Lamarckian
Non-cell autonomous
![Page 27: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/27.jpg)
Different sources of “dark selection” lead to different predictions
Stochastic ratcheted phenotypic switch
Lamarckian selection
Emerging signaling network behavior
Hidden Darwinian selection
![Page 28: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/28.jpg)
Experiments to differentiate between the scenarios
+/- Ruxolitinib
JAK2 V617F
Analyze in the Bone Marrow:
JAK2/Tyk heterodimers (by proximity ligation)ProliferationApoptosis
Blood:
Cytokines
~$15Kx50
(a) Tumour foci in the metaphysis but not in other regions of long bone (b), tumour foci in epiphysis and metaphysis but not in mid-diaphysis (c). 5x magnification. Figure from Holstead Jones et al, Nature, 2006
![Page 29: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/29.jpg)
Alternative #2: Dark selection/emergence
Before Rx
Activated Desensitized
Emerging signaling network behavior
InactivatedSensitized Activated
After Rx
![Page 31: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/31.jpg)
Alternative #2: Dark selection/emergence
![Page 32: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/32.jpg)
Integrating the continuous and CA models
+
Hybrid Continuous-Discrete Cellular Automaton
![Page 33: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/33.jpg)
Integrating experimental mouse data
+/- Ruxolitinib
JAK2 V617F
Analyze in the bone marrow:
Spatial analyses:Blood vesselsSTAT3 activation
+$3K
![Page 34: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/34.jpg)
Experiments to differentiate between the scenarios
Analyze in the bone marrow Before treatmentDuring remissionDuring response
JAK2/TYK heterodimers ProliferationApoptosis
Blood (weekly):Cytokines
$20K
x10 patients
![Page 35: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/35.jpg)
Scales of Cancer
![Page 36: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/36.jpg)
SA1: To determine whether the emergence of ruxolitinib resistance is a Darwinian, Lamarckian, or non-cell
autonomous process.
Heterodimerization at cytokine receptors Postdoc
~$12K~$18K
![Page 37: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/37.jpg)
Patient data
Cytokine data
Modeling
~$10K~$10K
SA2: To determine the kinetics of cytokine expression and resultant symptomatology in patients treated with ruxolitinib..
![Page 38: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/38.jpg)
To summarize
● Suite of novel integrated mathematical models test different evolutionary hypotheses and provide experimentally-testable insights
● Qualitative cytokine dynamics observed in the clinic can be captured in a simulation that models emergence of resistance
● Critically, the resistance paradox may depend on the tumor microenvironment, hidden selection, and network selection
![Page 39: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/39.jpg)
![Page 40: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/40.jpg)
Thanks
![Page 41: Dark selection for JAK/STAT-inhibitor resistance in CMML · Dark selection for JAK/STAT-inhibitor resistance in CMML The Orange team, the future is bright... Chronic Myelomonocytic](https://reader036.fdocuments.net/reader036/viewer/2022070816/5f1060ce7e708231d448d072/html5/thumbnails/41.jpg)
Questions?